SCHEMBL4748166

SCHEMBL4748166

CCCCCCCCCCCC[N+](C)(C)Cc1ccc(C(=O)[O-])cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 3/20 0.59
PSMD14 O00487 1/20 0.59
HSP90AA1 P07900 1/20 0.59
MMP2 P08253 1/20 0.59
MC4R P32245 1/20 0.59
RAD52 P43351 1/20 0.59
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
TP53 P04637 1/20 0.58
MAPK1 P28482 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
HTT P42858 3/20 0.56
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
HAO1 Q9UJM8 1/20 0.41
RARB P10826 4/20 0.41
THRA P10827 3/20 0.41
THRB P10828 3/20 0.41
ALDH1A1 P00352 1/20 0.41
RARA P10276 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cetalkonium SCHEMBL10584917 0.90 DNM1 (0.72) DNM1PSMD14HSP90AA1MMP2MC4R
Acetic Acid SCHEMBL7764904 0.89 DNM1 (0.65) DNM1PSMD14HSP90AA1MMP2MC4R
Benzododecinium SCHEMBL28001235 0.88 MEN1 (0.71) DNM1PSMD14HSP90AA1MMP2MC4R
Aminobenzoic Acid SCHEMBL11648178 0.87 DNM1 (0.63) DNM1PSMD14HSP90AA1MMP2MC4R
SCHEMBL4747603 0.86 DNM1 (0.66) DNM1PSMD14HSP90AA1MMP2MC4R
SCHEMBL5452094 0.86 DNM1 (0.66) DNM1PSMD14HSP90AA1MMP2MC4R
Succinic Acid SCHEMBL7768274 0.86 DNM1 (0.61) DNM1PSMD14HSP90AA1MMP2MC4R
Malonic Acid SCHEMBL7765990 0.86 DNM1 (0.61) DNM1PSMD14HSP90AA1MMP2MC4R
Cetalkonium SCHEMBL9133414 0.86 DNM1 (0.62) DNM1PSMD14HSP90AA1MMP2MC4R
Cetalkonium SCHEMBL9137664 0.85 DNM1 (0.60) DNM1PSMD14HSP90AA1MMP2MC4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008118445-A9 METHODS TO QUENCH LIGHT FROM OPTICAL REACTIONS PROMEGA CORP (US) 2008-12-04 WO disclosed
US-20080248511-A1 METHODS TO QUENCH LIGHT FROM OPTICAL REACTIONS PROMEGA CORPORATION 2008-10-09 US disclosed
WO-2008118445-A1 METHODS TO QUENCH LIGHT FROM OPTICAL REACTIONS PROMEGA CORPORATION (US) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080248511-A1 METHODS TO QUENCH LIGHT FROM OPTICAL REACTIONS GLO1, ESD, GLB1 DNM1 3032/4885PSMD14 2594/4885HSP90AA1 4675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.